University of Alberta

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1908-01-01

Employees: 10K

Market Cap: -

Website: http://www.ualberta.ca

Clinical Trials

Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation

Phase 4

Completed

Conditions: Kidney Transplant

Interventions: Biological: Zostavax (Live attenuated herpes zoster vaccine)
Biological: Placebo vaccine

First Posted Date: 2009-07-17

Last Posted Date: 2022-06-01

Lead Sponsor: University of Alberta

Target Recruit Count: 4

Registration Number: NCT00940940

Locations: 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada

Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack

Phase 4

Completed

Conditions: Ischemic Stroke
Transient Ischemic Attacks

Interventions: Drug: Antihypertensive agents and lipid lowering therapy
Other: Usual Care

First Posted Date: 2009-07-02

Last Posted Date: 2018-10-15

Lead Sponsor: University of Alberta

Target Recruit Count: 279

Registration Number: NCT00931788

Locations: 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada

Effectiveness of Docusate in Preventing/Treating Constipation in Palliative Care Patients

Not Applicable

Completed

Conditions: Constipation
Palliative Care

Interventions: Drug: Docusate Sodium, Sennoside
Drug: Sennoside + Placebo

First Posted Date: 2009-05-14

Last Posted Date: 2011-04-20

Lead Sponsor: University of Alberta

Target Recruit Count: 70

Registration Number: NCT00902031

Locations: 🇨🇦
St. Joseph's Auxiliary Care Hospital, Edmonton, Alberta, Canada
🇨🇦
CapitalCare Norwood, Edmonton, Alberta, Canada
🇨🇦
Mel Miller Hospice at Edmonton General Continuing Care Hospital, Edmonton, Alberta, Canada

Trabectome Versus Trabeculectomy With Mitomycin C in Patients With Open Angle Glaucoma

Phase 3

Terminated

Conditions: Open Angle Glaucoma

Interventions: Procedure: Trab-IOL
Procedure: Trabectome-IOL

First Posted Date: 2009-05-13

Last Posted Date: 2016-02-25

Lead Sponsor: University of Alberta

Target Recruit Count: 19

Registration Number: NCT00901108

Locations: 🇨🇦
Royal Alexandra Hospital, Edmonton, Alberta, Canada

Scope Pilot Research Study

Completed

Conditions: Colorectal Cancer

First Posted Date: 2009-05-06

Last Posted Date: 2011-03-08

Lead Sponsor: University of Alberta

Target Recruit Count: 1248

Registration Number: NCT00893503

Locations: 🇨🇦
Walter C. MacKenzie Centre, University of Alberta, Edmonton, Alberta, Canada
🇨🇦
Royal Alexandra Hospital, Edmonton, Alberta, Canada

Alberta Clinical Trial in Optimizing Hypertension

Not Applicable

Completed

Conditions: Hypertension

Interventions: Other: Enhanced pharmacist care
Other: Usual Care

First Posted Date: 2009-04-09

Last Posted Date: 2015-04-28

Lead Sponsor: University of Alberta

Target Recruit Count: 248

Registration Number: NCT00878566

Locations: 🇨🇦
University of Alberta, Edmonton, Alberta, Canada

Quality of Life Outcomes and Economic Impacts of Bariatric Surgery

Completed

Conditions: Obesity

First Posted Date: 2009-02-25

Last Posted Date: 2013-05-21

Lead Sponsor: University of Alberta

Target Recruit Count: 500

Registration Number: NCT00850356

Locations: 🇨🇦
Royal Alexandra Hospital, Edmonton, Alberta, Canada

A Trial Comparing Propofol to Midazolam Plus Meperidine Sedation for Outpatient Colonoscopy

Not Applicable

Completed

Conditions: Sedation

Interventions: Drug: propofol (sedation for outpatient colonoscopy)
Drug: midazolam plus meperidine (sedation for outpatient colonoscopy)

First Posted Date: 2009-02-20

Last Posted Date: 2009-02-20

Lead Sponsor: University of Alberta

Target Recruit Count: 92

Registration Number: NCT00848861

Locations: 🇨🇦
University of Alberta, Edmonton, Alberta, Canada

A Trial of Four Different Bowel Cleansing Regimens Prior to Colonoscopy

Not Applicable

Completed

Conditions: Bowel Preparation

Interventions: Procedure: colonoscopy bowel prep

First Posted Date: 2009-01-28

Last Posted Date: 2016-06-13

Lead Sponsor: University of Alberta

Target Recruit Count: 200

Registration Number: NCT00831064

Locations: 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada

Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients

Completed

Conditions: Cytomegalovirus Infection

First Posted Date: 2009-01-07

Last Posted Date: 2012-04-23

Lead Sponsor: University of Alberta

Target Recruit Count: 131

Registration Number: NCT00817908

Locations: 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy